66270/Wellcome Trust/United Kingdom[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2006	1
2007	2
2008	1
2024	0

Page 1

Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice.

Guidetti P, Bates GP, Graham RK, Hayden MR, Leavitt BR, MacDonald ME, Slow EJ, Wheeler VC, Woodman B, Schwarcz R. Guidetti P, et al. Neurobiol Dis. 2006 Jul;23(1):190-7. doi: 10.1016/j.nbd.2006.02.011. Epub 2006 May 12. Neurobiol Dis. 2006. PMID: 16697652

Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation.

Zourlidou A, Gidalevitz T, Kristiansen M, Landles C, Woodman B, Wells DJ, Latchman DS, de Belleroche J, Tabrizi SJ, Morimoto RI, Bates GP. Zourlidou A, et al. Hum Mol Genet. 2007 May 1;16(9):1078-90. doi: 10.1093/hmg/ddm057. Epub 2007 Mar 14. Hum Mol Genet. 2007. PMID: 17360721

Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.

Weiss A, Klein C, Woodman B, Sathasivam K, Bibel M, Régulier E, Bates GP, Paganetti P. Weiss A, et al. J Neurochem. 2008 Feb;104(3):846-58. doi: 10.1111/j.1471-4159.2007.05032.x. Epub 2007 Nov 6. J Neurochem. 2008. PMID: 17986219 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year